{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"}]}],"title":"No. of patients with dysphagia grade 0"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"4"}]}],"title":"No. of patients with dysphagia grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}],"title":"No. of patients with dysphagia grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"title":"No. of patients with dysphagia grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"title":"No. of patients with dysphagia grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"}]}],"title":"Not Accessible"}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"9"}],"units":"Participants"}],"description":"Grade of swallowing dysfunction as measured by the modified barium swallow score: grade 1, normal; grade 2, within functional limits; grade 3, mild impairment; grade 4, mild to moderate impairment; grade 5, moderate impairment; grade 6, moderate to severe impairment; grade 7, severe impairment","groups":[{"description":"Patients undergo specialized nutrition therapy (SNT) including dietitian counseling and calorie goal instruction.","id":"OG000","title":"Arm IA"},{"description":"Patients undergo SNT and low-weight resistance training (LWRT).","id":"OG001","title":"Arm IB"},{"description":"Patients receive amifostine subcutaneously (SC) 30-60 minutes prior to each dose of intensity-modulated radiotherapy (IMRT). Patients also undergo SNT as in arm IA.","id":"OG002","title":"Arm IIA"},{"description":"Patients receive amifostine SC 30-60 minutes prior to each dose of IMRT. Patients also undergo SNT and LWRT as in arm IB.","id":"OG003","title":"Arm IIB"}],"paramType":"NUMBER","populationDescription":"One patient (Arm 2B) did not undergo the 6-month study","reportingStatus":"POSTED","timeFrame":"6 months after concurrent chemotherapy and radiation","title":"Number of Patients With Each Degree of Swallowing Dysfunction","type":"PRIMARY","unitOfMeasure":"participants"}